MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Operational Performance Effects and Neurophysiology in Partial Gravity
Not Applicable
Completed
- Conditions
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT06736652
- Locations
- 🇫🇷
NoveSpace, Mérignac, France
Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06716931
- Locations
- 🇺🇸
Neuromuscular Diagnostic Center. Massachusetts General Hospital, Boston, Massachusetts, United States
Ivosidenib As Post-HSCT Maintenance for AML
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06707493
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Investigating the Effects of Tube Feeds on Glycemia and Sleep in Adults With Cystic Fibrosis-Related Diabetes
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06700889
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06698848
- Locations
- 🇺🇸
Massachusetts General Hosipital, Boston, Massachusetts, United States
Guideline Directed Medical Therapy in Patients with Heart Failure
Recruiting
- Conditions
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06700213
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
Phase 3
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06691893
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06691217
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Auditory Stimulation Effect on Brain Oscillations and Sleep Dependent Learning
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06688526
A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06686901
© Copyright 2024. All Rights Reserved by MedPath